Newsbenzinga
Omnipod Sales Soar, But Insulet's Outlook Cut Sparks Stock Selloff
· Published
Article summary
Insulet (PODD) stock falls despite beating Q2 earnings as the company lowers its full-year 2026 revenue guidance. Get details here.
An excerpt from the original article.
Comments —
Loading comments…